Delivery Order SPE2DB20D3103-SPE2DB25FM9N6

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,939.67 firm fixed-price contract is for the supply of Descovy 200-25 mg tablet. The contract has a period of performance through December 19, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,889.96, is for the supply of Descovy 200-25 mg tablets to support federal healthcare programs. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through December 2024, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 IDC with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,574.17, is for the delivery of Descovy 200-25 mg tablets, a prescription medication, to support federal healthcare programs. The contract has a fixed-price, firm-fixed-price structure and a period of performance through May 2024. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,962.31, is for the delivery of Descovy 200-25 mg tablets. The contract is a delivery order with a firm fixed price and has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Descovy 200-25 mg tablets, a medication used for the treatment of HIV. The contract has a ceiling value of $11,258.37 and runs through October 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The $9,615.52 firm-fixed-price contract has a completion date of March 2, 2023. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The $56,135.36 firm-fixed-price contract has an ultimate completion date of January 13, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $25,761.15 for the supply of the drug Descovy 200-25 mg Tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 20, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,241.49, is for the supply of Descovy 200-25 mg tablets, a prescription medication, to support military healthcare programs. The contract is a Firm Fixed Price delivery order that runs through March 3, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the supply of Descovy 200-25mg tablets, a specialty prescription medication, with a ceiling value of $31,653.49 and a completion date of July 11, 2022. This delivery order is issued under a larger $999,999,999.00 indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM9N6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablet. The contract has a total ceiling value of $9,251.31 and runs through March 7, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 6/5/25, 10:29 AM